News & Updates

Show Multimedia Only

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

10 Mar 2026 by

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with diabetes or heart diseases is not associated with increased risk of optic nerve or vision-threatening events, and plays a role in improving the long-term success rate of curative catheter ablation for atrial fibrillation (AF) in cardiac patients with obesity, researchers from the University of Hong Kong (HKU) have found.

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

10 Mar 2026

High BMI ups risk of vascular-related dementia

09 Mar 2026 by

A Mendelian randomization (MR) study shows an association between a high BMI and a higher risk of vascular-related dementia, which is partly mediated through high blood pressure (BP).

High BMI ups risk of vascular-related dementia

09 Mar 2026

Growth hormone replacement therapy for GHD: Early diagnosis and treatment initiation improves response

09 Mar 2026 by

Diagnosis of growth hormone deficiency (GHD) is important and should be made early as it is easily treatable with GH replacement (somatropin) therapy. In an interview with MIMS Doctor, Dr Wai-Man But gave an overview of the diagnosis and management of GHD, and shared a patient case who achieved growth normalization with early initiation of GH treatment.

Growth hormone replacement therapy for GHD: Early diagnosis and treatment initiation improves response

09 Mar 2026

Cardioprotection with GLP-1RA in T2D greater when combined with healthy lifestyle

09 Mar 2026

Treatment with a glucagon-like peptide-1 receptor agonist (GLP-1RA) in combination with adherence to healthy lifestyle habits yields a greater reduction in the risk of cardiac events in individuals with type 2 diabetes (T2D) compared with GLP-1RA treatment alone, according to a prospective study.

Cardioprotection with GLP-1RA in T2D greater when combined with healthy lifestyle

09 Mar 2026

Hyperlipidaemia accompanying hypertension spells higher healthcare cost for seniors

07 Mar 2026 by

Older adults seeking care in the public primary care setting in Singapore often present with hyperlipidaemia and hypertension, a multimorbidity combination that drives up healthcare costs the most, as shown in a study.

Hyperlipidaemia accompanying hypertension spells higher healthcare cost for seniors

07 Mar 2026

Obesity in parents linked to MASLD risk in adult offspring

07 Mar 2026

Excess parental adiposity prior to pregnancy is associated with increased likelihood of metabolic dysfunction-associated steatotic liver disease (MASLD) development in offspring as adults, as mediated by higher BMI throughout childhood, according to a study.

Obesity in parents linked to MASLD risk in adult offspring

07 Mar 2026

Early glycaemic control helps lower dementia risk among new metformin users

05 Mar 2026

A recent study provides evidence lending support to established recommendations for early glycaemic control in patients with type 2 diabetes to reduce their risk of developing dementia.

Early glycaemic control helps lower dementia risk among new metformin users

05 Mar 2026

BP control maintained with relacorilant in patients with Cushing’s syndrome

05 Mar 2026

Treatment with relacorilant in adult patients with endogenous hypercortisolism helps maintain blood pressure (BP) control, according to a phase III study.

BP control maintained with relacorilant in patients with Cushing’s syndrome

05 Mar 2026

Does hormone therapy raise risk of IBD flare in gender-diverse adults?

02 Mar 2026

The risk of an inflammatory bowel disease (IBD) flare does not increase in the year after initiating gender-affirming hormone therapy (GAHT), but individuals with IBD prior to hormone start and those receiving testosterone have a higher likelihood of having an IBD flare, a study has shown.

Does hormone therapy raise risk of IBD flare in gender-diverse adults?

02 Mar 2026

Better sleep yields greater weight loss for breast cancer survivors

02 Mar 2026 by

Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.

Better sleep yields greater weight loss for breast cancer survivors

02 Mar 2026

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

High BMI ups risk of vascular-related dementia

High BMI ups risk of vascular-related dementia

Growth hormone replacement therapy for GHD: Early diagnosis and treatment initiation improves response

Growth hormone replacement therapy for GHD: Early diagnosis and treatment initiation improves response

Cardioprotection with GLP-1RA in T2D greater when combined with healthy lifestyle

Cardioprotection with GLP-1RA in T2D greater when combined with healthy lifestyle

Hyperlipidaemia accompanying hypertension spells higher healthcare cost for seniors

Hyperlipidaemia accompanying hypertension spells higher healthcare cost for seniors

Obesity in parents linked to MASLD risk in adult offspring

Obesity in parents linked to MASLD risk in adult offspring

Early glycaemic control helps lower dementia risk among new metformin users

Early glycaemic control helps lower dementia risk among new metformin users

BP control maintained with relacorilant in patients with Cushing’s syndrome

BP control maintained with relacorilant in patients with Cushing’s syndrome

Does hormone therapy raise risk of IBD flare in gender-diverse adults?

Does hormone therapy raise risk of IBD flare in gender-diverse adults?

Better sleep yields greater weight loss for breast cancer survivors

Better sleep yields greater weight loss for breast cancer survivors